Jove
Visualize
Contact Us

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

17.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.1K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.7K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Genetic Diversity of <i>Listeria</i> Detected in the Production Environment of Meat Processing.

Molecular genetics, microbiology and virology : Molekulyarnaya genetika, mikrobiologiya i virusologiya·2023
Same journal

Comparison of Fragments in Human Hemostatic Proteins That Mimics Fragments in Proteins of A/H1N1 Viruses and Coronaviruses.

Molecular genetics, microbiology and virology : Molekulyarnaya genetika, mikrobiologiya i virusologiya·2023
Same journal

COVID-19, Influenza, and Other Acute Respiratory Viral Infections: Etiology, Immunopathogenesis, Diagnosis, and Treatment. Part 2. Other Acute Respiratory Viral Infections.

Molecular genetics, microbiology and virology : Molekulyarnaya genetika, mikrobiologiya i virusologiya·2023
Same journal

Oral Delivery of SARS-CoV-2 DNA Vaccines Using Attenuated <i>Salmonella typhimurium</i> as a Carrier in Rat.

Molecular genetics, microbiology and virology : Molekulyarnaya genetika, mikrobiologiya i virusologiya·2023
Same journal

Production and Characterization of Rat Monoclonal Antibodies against the PAL Antigen of <i>Legionella</i> spp.

Molecular genetics, microbiology and virology : Molekulyarnaya genetika, mikrobiologiya i virusologiya·2022
Same journal

COVID-19, Influenza, and Other Acute Respiratory Viral Infections: Etiology, Immunopathogenesis, Diagnosis, and Treatment. Part I. COVID-19 and Influenza.

Molecular genetics, microbiology and virology : Molekulyarnaya genetika, mikrobiologiya i virusologiya·2022
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Nov 2, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K

SARS-CoV-2 and Patent Activity.

I B Nikitina1, E A Smirnova1

  • 1Federal Institute of Industrial Property, Federal Service for Intellectual Property, Patents, and Trademarks, 125993 Moscow, Russia.

Molecular Genetics, Microbiology and Virology : Molekulyarnaya Genetika, Mikrobiologiya I Virusologiya
|June 9, 2021
PubMed
Summary

Patent activity for coronavirus and SARS-CoV-2 inventions shows steady interest from 1996-2020. The study also covers patentable vaccine inventions for coronaviruses.

Keywords:
Keywords: patent lawSARS-CoV-2coronavirusinvention

More Related Videos

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.5K
Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro
09:26

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro

Published on: June 6, 2025

802

Related Experiment Videos

Last Updated: Nov 2, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.5K
Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro
09:26

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro

Published on: June 6, 2025

802

Area of Science:

  • Biotechnology
  • Intellectual Property Law

Background:

  • Coronaviruses, including SARS-CoV-2, have been a focus of scientific research and development.
  • Patent activity reflects the evolving landscape of innovation in response to emerging infectious diseases.

Purpose of the Study:

  • To analyze patent trends related to coronavirus and SARS-CoV-2 inventions.
  • To identify the scope of patentable subject matter for coronavirus vaccines.

Main Methods:

  • Bibliometric analysis of patent databases.
  • Review of patent applications concerning coronaviruses and SARS-CoV-2.
  • Examination of patent law principles applicable to vaccine technologies.

Main Results:

  • A consistent increase in patent filings related to coronaviruses and SARS-CoV-2 was observed between 1996 and 2020.
  • Inventions concerning vaccines represent a significant category within coronavirus-related patent applications.
  • The study illustrates the dynamic nature of intellectual property in the field of virology.

Conclusions:

  • There is sustained inventor interest in developing coronavirus countermeasures, including vaccines.
  • Understanding patent law is crucial for protecting innovations in vaccine development.
  • Patent analysis provides insights into research trajectories and commercial interest in coronaviruses.